资源描述：
《casestudy写作-Aurobindo制药公司案例研究》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、casestudy写作-Aurobindo制药公司案例研究A-OnAurobindoPharmaGlobalstrategyforIndianpharmacycompaniesandtheopportunityinemergingmarkets:AcasestudyonAurobindoPharmaFocusAim:TounderstandthetrendsinIndianpharmacycompanieswhichhavebeenrecentlygoingglobalbyinvestingabroadwithanintentionform
2、arketexpansion?网课代巾筠wangke.lxws.netObjectives:TofindoutthestrengthsoftheIndianPharmaceuticalIndustryandanalysethepatternofMergersandAcquisitionsbyvariouscompaniesacrosstheglobe.TothrowlightonthestrategiesfollowedbyAurobindoPharmainacquiringotherpharmacompanies・ContextThere
3、searchincludesstrategyoftheemergingpharmaceuticalcompaniesinIndiaandunderstandsthetrendsandprocessofthecompaniesthathavebeengoingglobaltoexpandtheirmarketintheworld-wide.Literaturereview:Inpharmaceuticalsectoraroundtheworld,Indiaranks4thintermsofvolumeand13thintermsofvalue
4、.Intheyear2006thevaluewasUSD7.42billion,thegrowthhasbeenincreasedby12.9%overthepreviousyea匚Inthistotalsales90%ofthesalesareaccountedasgenericsandtheremainingarcpatenteddrugs・Nowaday'sgovernmentsofvariouscountries,patientsandindustriesarepullingattentiontowardsgenericdrugs,
5、duetolowerincostandlessR&Dinvestmentthancomparestothatofthepatenteddrugs.Intheyear2005thegenericmarkethasbeenincreasedby20%intheworldwhichisfourtimesthatofthepatenteddrugsandthreetimesthatofthepharmaceuticalsmarket.USmarketalonehadacquired44%ofthegenericdrugs(Pharmabiz,200
6、9).TheCompoundAnnualGrowthRale(CAGR)ofgenericdrugsinIndianpharmaceuticalshasbeenincreasedby16.6%duringtheperiodof2001-05・TheexpectedCAGRduringtheperiodof2009-14wouldbe13.2%andapproximatelythetotalvaluemayreach$15,490min2014(ResearchandMarkets,2009).Intheyear2009inIndiather
7、eweremorethan80FDAapprovedplants,Italy(55)andChina(27).TheIndianpharmaceuticalscompanieslikeCipla,D匚Reddy'slab;Wockhardt,LupinandNicholasPiramalarcdoingwellindevelopedmarketsuchasUSandEurope.Thesecompanieshaveexcitingvaluesinfonnulation,bulkdrugs,generics,noveldrugdelivery
8、system,newchemicalentities,biotechnologyetc(ResearchandMarkets,2007).4.1Indianpharmaceuti
